The role of cyclooxygenase-2 in breast cancer: review
Spindle cell lesions of the breast-the pathologic differential diagnosis
HER2/neu in systemic therapy for women with breast cancer: a systematic review
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials
Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells
Core wash cytology of breast lesions by ultrasonographycally guided core needle biopsy
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone
1,1-Bis(3′indolyl)-1-1(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negatie breast cancer cells by activation of multiples pathways
Effectiveness of a self-administered, home-based exercise rehabilitation program for women following a modified radical mastectomy and axillary node dissection: a preliminary study
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study
Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies
A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1
CCDN1 amplification and cylin DI expression in breast cancer and their relation with proteomic subgroups and patient outcome
Assessment of clinical response after two cycles of primary chemotherapy in breast cancer
A phase-III trial of dexorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breat cancer: results to of the ERASME 3 study
HER2 status in hormone receptor positive premonopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information
Prevalence and prognostic and predictive relevance of PRAME in breast cancer
Assessing the economic burden of breast cancer in a US managed care population
Health-related quality of life before and after a breast cancer diagnosis
The impact of diabetes on survival following breast cancer
Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study
Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer